Antagonistas da vitamina K versus heparina de baixo peso molecular para o tratamento de longo prazo do tromboembolismo venoso sintomático: Mais uma revisão da Cochrane Brazil https://t.co/QA6UnAgwcT https://t.co/kpIr6COl6Y
#CochraneEvidence: Vitamin K antagonists versus low‐molecular‐weight heparin for the long term treatment of symptomatic venous thromboembolism https://t.co/7llnqZrwzt
RT @CochraneVasc: #CochraneEvidence update LMWH vs VKA for longterm #VTE treatment @VSGBI @isth @ESVM_ @AntiCoagEurope @VascularSVS http…
#CochraneEvidence update LMWH vs VKA for longterm #VTE treatment @VSGBI @isth @ESVM_ @AntiCoagEurope @VascularSVS https://t.co/ulYaFLzqrZ
#CochraneEvidence update LMWH vs VKA for longterm #VTE treatment @VSGBI @isth @ESVM_ @AntiCoagEurope #clot https://t.co/ulYaFLzqrZ
静脈塞栓症、症候性深部静脈血栓症に対するVitaminK 拮抗剤(ワーファリン等)低分子量ヘパリンの効果の比較。中等度上のエビデンスで両者に効果の差はない。出血等副作用のリスクはLMWH少ないが、信頼性研究に限るとそれも差はなくなる。https://t.co/4FcFBD4Gkb
Vitamin K antagonists or low-molecular-weight heparin for long term treatment of symptomatic blood clots | Cochrane https://t.co/X90DSDsHOV https://t.co/ZXDbFKtiqR
RT @CECLibrary: Vitamin K antagonists versus low-molecular-weight heparin for the long term treatment of symptomatic ... - PubMed https://t…
Vitamin K antagonists versus low-molecular-weight heparin for the long term treatment of symptomatic ... - PubMed https://t.co/gLfZD0ecFW
(Cochrane) No hay diferencias entre cumarinas y HBPM en la prevención del TEV https://t.co/Egr4CAem9u
AVK vs HBPM en tto crónico d TVP sintomát→no clara diferencia en prevención morbimortalidad ni en sangrado[Cochrane] https://t.co/XdUCiVr3Dl
CochraneLibrary: Vitamin K antagonists or low-molecular-weight heparin for long term treatment of symptomatic blood… https://t.co/UcEKsMaRrz https://t.co/UhHA0wHI4c
Vitamin K antagonists or low-molecular-weight heparin for long term treatment of… https://t.co/s6L90FjFFS
Vitamin K antagonists versus low-molecular-weight heparin for the long term treatment of… https://t.co/4pcTyVBwVf